4DECEMBER - 2022TECH OUTLOOKIN MY OPINION12LAST WORD30Jon Kallay, Senior Technology and Market Development Manager, Charles River LaboratoriesDeveloping Patient-Centric Precision Oncology Therapies: Begin With The End In MindSanjay Konagurthu, Senior Director, Science And Innovation, Pharma Services, Thermo Fisher Scientific08Rapid Release Quality Control Solution for Cellular TherapiesCOV ER STORYDavid Hahn, Worldwide HeadPURPOSE-DRIVEN AND STRATEGIC: THE GO-TO MEDICAL AFFAIRS PARTNERTHE MEDICAL AFFAIRS COMPANY
< Page 3 | Page 5 >